Clementia Pharmaceuticals clementiapharma.com


Public list: Smart Money VCs (6327) Pharma Startups (6570)

Clementia Pharmaceuticals (NASDAQ: CMTA) is a clinical stage biopharmaceutical company that is developing palovarotene, an investigational retinoic acid receptor gamma (RARγ) selective agonist, for the treatment of individuals who are affected by fibrodysplasia ossificans progressiva (FOP), multiple osteochondromas (MO) and other diseases.

Clementia Pharmaceuticals (NASDAQ: CMTA) is a clinical stage biopharmaceutical company that is developing palovarotene, an investigational retinoic acid receptor gamma (RARγ) selective agonist, for the treatment of individuals who are affected by fi...Show all

Company (Acquired)

Phone: +1 (514) 940-3600

Fax:

1000 de la Gauchetière O
Suite 1200
Montreal, H3B 4W5
Quebec, Canada

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Clementia Pharmaceuticals $92.5M Apr 18, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Clementia Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 7 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Antisense oligonucleotides and methods of use thereof Nov 30, 2016 Application